Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 11;13(1):e063161.
doi: 10.1136/bmjopen-2022-063161.

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis

Bei Yang  1 , Lin Han  1 , Yin Wang  2 , Kangyao Cheng  2
Affiliations

Effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections on glycaemic control among older adults with type 2 diabetes: protocol for systematic review and meta-analysis

Bei Yang et al. BMJ Open. .

Abstract

Introduction: Insulin therapy plays an irreplaceable role in glycaemic control among older adults with type 2 diabetes mellitus (T2DM) and can be administered by either multiple daily injections (MDI) of insulin or by a continuous subcutaneous insulin infusion (CSII) pump. Many clinical trials have compared the effects of CSII pumps and MDI in various diabetic populations, but there has been no systematic review and meta-analysis focusing on older adults with T2DM. This study aims to determine whether the CSII pump is associated with better glycaemic control relative to the MDI in older adults with T2DM.

Methods and analysis: PubMed, Medline, Cochrane Library, Web of Science core collection, China National Knowledge Infrastructure (CNKI), Wan Fang Database, Chinese Science and Technology Journal Database (VIP) and Chinese Biomedical Literature Database (SinoMed) will be searched from inception to December 2021. Only randomised controlled trials will be included, and the language of the selected studies will be restricted to English and Chinese. Two researchers will independently screen the studies, extract data, assess the risk of bias and evaluate the quality of evidence. Any disagreement will be resolved by consensus or by a third researcher. Data analysis and synthesis will be conducted using RevMan V.5.3. Subgroup analysis, sensitivity analysis and publication bias assessment will be performed, as necessary.

Ethics and dissemination: As this study will not contain personal information, ethical approval will not be required. The results of the study will be published in a peer-reviewed journal or at relevant conference.

Prospero registration number: CRD42021283729.

Keywords: Change management; General diabetes; Protocols & guidelines.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The PRISMA flow diagram shows the details of research selection. PRISMA, Preferred Reporting Items for Systematic review and Meta-Analysis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. International Diabetes Federation . The IDF diabetes atlas. 10th ed. IDF, 2021.
    1. About diabetes -type 2 diabetes, 2020. Available: https://idf.org/aboutdiabetes/type-2-diabetes.html [Accessed 25 Dec 2021].
    1. NHS Digital . National diabetes audit report 1 care processes and treatment targets 2017-18, 2018. Available: https://digital.nhs.uk/data-and-information/publications/statistical/nat... [Accessed 25 Dec 2021].
    1. Bellary S, Kyrou I, Brown JE, et al. . Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol 2021;17:534–48. 10.1038/s41574-021-00512-2 - DOI - PubMed
    1. Lee PG, Halter JB. The pathophysiology of hyperglycemia in older adults: clinical considerations. Diabetes Care 2017;40:444–52. 10.2337/dc16-1732 - DOI - PubMed

Publication types